Clinical
RSSArticles
-
Comparing Insulin Treatments for Diabetic Patients
Authors of two studies suggested that 32 weeks’ treatment with insulin degludec vs. insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemic episodes.
-
Exploring the Rising Prices of Generic Drugs
Study: As competition among generic drugs decreases, prices go up.
-
Investigators Tackle Antimicrobial Resistance
Researchers suggested that “modified use of antimicrobial agents and public health interventions, coupled with novel antimicrobial strategies, may help mitigate the effect of multidrug-resistant organisms in the future.”
-
Antibiotics for Upper Respiratory Infections in Elderly Patients
Physicians who were more likely to prescribe an antibiotic for an acute upper respiratory tract infection included mid- and late-career physicians, physicians trained outside of Canada or the United States, and high-volume physicians.
-
New PPI Mortality Data: Is There a Risk?
Are proton pump inhibitors associated with excess risk of mortality? That is the finding of a highly publicized study.
-
The Potential Long-term Payoff of Good Initial Diabetes Control
The results of a recent study encourage clinicians to pursue the best control of type 2 diabetes they can attain without incurring significant adverse events.
-
Dietary Omega-3 Fatty Acids Inversely Associated with Diabetic Retinopathy
It remains to be determined whether this isolated ingredient from fish, when taken as a single-entity intervention, will provide similar benefits.
-
The Best BP for High-risk Hypertension Patients
The debate continues.
-
Identification of Pneumococcal Pneumonia
There is no reason to consider urine antigen testing as indicative of less pneumonia lethality.
-
Rheumatoid Arthritis Disease Activity and Calprotectin Levels
Calprotectin may provide a metric for confirmation of optimized control of rheumatoid arthritis, providing additional insight into disease activity beyond clinical symptoms alone.